GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR (4x96)
GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR is a Multiplex Real-Time PCR with CE-IVD marking for the direct qualitative pathogen detection of the novel Coronavirus (SARS-CoV-2). Particularly in the early phase of a virus infection, the direct diagnostic of the pathogen is key.
This product is not available for online purchase for customers located in the US or in Germany.
The GSD NovaPrime® SARS-CoV-2 (COVID-19) RT-PCR is intended for the qualitative determination of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) genomic RNA extracted from human respiratory (nasal wash/swab, nasopharyngeal wash/swab, oropharyngeal swab and bronchoalveolar lavage) specimen types.
The assay simultaneously detects two target sequences inside the N gene. The multiplex PCR allows a streamlined workflow in one reaction and provides results in approximately 1 hours. An extraction/inhibition control and a positive control is included in the reagents.
The PCR assay demonstrates excellent performance with a 100 % Negative and Positive Percent Agreement (NPA, PPA) for all tested samples and no cross-reactivity with other common widely spread coronaviruses. The analytic sensitivity shows a limit of detection of 3.75 copies/reaction.
|No. of tests||4x96|
|Time to Result||Approximately 1 hour|
|PCR cycler platforms||Extraction systems: ▪ Eurofins GeneScan Technologies: GSD NovaPrime® RNA Extraction AE1 and AE2 ▪ bioMérieux: NUCLISENS® easyMAG® or EMAG® Real-Time PCR Cyclers: ▪ Agilent Technologies: AriaDxTM, AriaMxTM ▪ Applied BiosystemsTM: ABI Prism® 7500 SDS, 7500 Fast SDS, Quantstudio™ 5 ▪ Bio-Rad: CFX96 Touch® ▪ Roche Diagnostics: LightCycler® 480 Instrument II Further validation in progress.|